The study found a 38% decrease in asthma symptoms and a 31% increase in child quality of life. Parents also experienced a 16% increase in perceived competence of managing their child's illness. The program used a multi-disciplinary approach to help patients control their disease.
Sarcoidosis is a mysterious disease affecting 30 people per 100,000 in the US, characterized by granulomas and inflammation. New research suggests shared environmental exposure may lead to the disease, which often affects young adults and has no cure.
Researchers found that rush immunotherapy targeting a single allergen makes distinct changes in T cells and prevents allergic reactions. The study showed that T cells produce more interferon gamma, an element that lowers allergic responses, and shut off production of pro-allergic cytokines.
A study found that 92 percent of children using common asthma medications reported more frequent use than actual, with actual use rates as low as 62.1 percent for beta-agonists and 58.4 percent for corticosteroids.
Researchers found that using beta-agonists regularly causes no adverse health effects and may be a sign of worsening asthma. The study followed 255 patients with mild asthma, ages 12 to 55, for 6 months, finding no significant differences in lung function or quality of life between regular-use and as-needed use groups.
A rare lung disease thought to affect only people from Japan, China, and Korea has been diagnosed in five US patients with no Asian ancestry. Long-term antibiotic use can effectively treat the condition, but mortality rates remain high if left untreated.